These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 23141847

  • 21. Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.
    Jover E, Roldán V, Gallego P, Hernández-Romero D, Valdés M, Vicente V, Lip GY, Marín F.
    Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):627-33. PubMed ID: 22609214
    [Abstract] [Full Text] [Related]

  • 22. Association of Atrial Fibrillation and Stroke: Analysis of Maccabi Health Services Cardiovascular Database.
    Shames J, Weitzman S, Nechemya Y, Porath A.
    Isr Med Assoc J; 2015 Aug; 17(8):486-91. PubMed ID: 26394490
    [Abstract] [Full Text] [Related]

  • 23. Clinical outcome in Japanese elderly patients with non-valvular atrial fibrillation taking warfarin: a single-center observational study.
    Naganuma M, Shiga T, Sato K, Murasaki K, Hashiguchi M, Mochizuki M, Hagiwara N.
    Thromb Res; 2012 Jul; 130(1):21-6. PubMed ID: 22137743
    [Abstract] [Full Text] [Related]

  • 24. Risk of bleeding in low-risk atrial fibrillation patients on warfarin waiting for elective cardioversion.
    Poli D, Antonucci E, Grifoni E, Paoletti O, Rancan E, Dentali F, Testa S.
    Thromb Res; 2012 May; 129(5):588-90. PubMed ID: 21975030
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
    Lee BH, Park JS, Park JH, Park JS, Kwak JJ, Hwang ES, Kim SK, Choi DH, Kim YH, Pak HN.
    J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Hemorrhagic complications of oral anticoagulant therapy: results of a prospective multicenter study ISCOAT (Italian Study on Complications of Oral Anticoagulant Therapy)].
    Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berretini M, Musolesi S.
    G Ital Cardiol; 1997 Mar; 27(3):231-43. PubMed ID: 9244725
    [Abstract] [Full Text] [Related]

  • 31. Paroxysmal atrial fibrillation is more prevalent than persistent atrial fibrillation in acute stroke and transient ischemic attack patients.
    Rizos T, Wagner A, Jenetzky E, Ringleb PA, Becker R, Hacke W, Veltkamp R.
    Cerebrovasc Dis; 2011 Mar; 32(3):276-82. PubMed ID: 21893980
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis.
    Lip GY, Andreotti F, Fauchier L, Huber K, Hylek E, Knight E, Lane DA, Levi M, Marin F, Palareti G, Kirchhof P, Document reviewers:, Collet JP, Rubboli A, Poli D, Camm J.
    Europace; 2011 May; 13(5):723-46. PubMed ID: 21515596
    [Abstract] [Full Text] [Related]

  • 34. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
    Apostolakis S, Lane DA, Guo Y, Buller H, Lip GY.
    J Am Coll Cardiol; 2012 Aug 28; 60(9):861-7. PubMed ID: 22858389
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study.
    Friberg L, Rosenqvist M, Lip GY.
    Circulation; 2012 May 15; 125(19):2298-307. PubMed ID: 22514252
    [Abstract] [Full Text] [Related]

  • 38. The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation.
    Keskar V, McArthur E, Wald R, Harel Z, Zimmerman D, Molnar AO, Garg AX, Lam NN, McCallum MK, Bota SE, Perl J, Sood MM.
    Kidney Int; 2017 Apr 15; 91(4):928-936. PubMed ID: 28017326
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Efficacy and safety of vitamin K-antagonists (VKA) for atrial fibrillation in non-dialysis dependent chronic kidney disease.
    Kooiman J, van Rein N, Spaans B, van Beers KA, Bank JR, van de Peppel WR, del Sol AI, Cannegieter SC, Rabelink TJ, Lip GY, Klok FA, Huisman MV.
    PLoS One; 2014 Apr 15; 9(5):e94420. PubMed ID: 24817475
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.